MedPAC Weighs Medicare Drug Payment Reforms On Thursday

Congressional Medicare advisers will take up the hot-button issue of pharmaceutical costs Thursday (March 3) with sessions on Medicare Parts D and Part B drug reimbursement and a session on oncology services that also will touch on drug payment policy. However, the payment policies listed in the session briefs would directly affect providers, plans and beneficiaries and would not directly affect drug prices. First up is a panel that focuses on how Part D plans are reimbursed, which Medicare Payment...